Seeking Alpha
Seeking Alpha Portfolio App for iPad
Finance
(1)
Market Currents

Molecular diagnostics firm Cepheid (CPHD) up 6% AH as it gets FDA clearance for a test that...

  • Thursday, September 24, 2009, 4:45 PM ET
    Molecular diagnostics firm Cepheid (CPHD) up 6% AH as it gets FDA clearance for a test that detects genetic variations related to an increased risk of blood clots. (PR)
Track new comments on this story

This news story has 1 comment:

  • Not much activity for good news
    24 Sep 2009, 05:15 PM Reply Like
Other date
DJIA (DIA) S&P 500 (SPY)